King Michael 4
4 · SAB Biotherapeutics, Inc. · Filed Nov 30, 2023
Insider Transaction Report
Form 4
King Michael
CHIEF FINANCIAL OFFICER
Transactions
- Purchase
Common Stock
2023-11-30$0.90/sh+5,000$4,500→ 5,000 total
Footnotes (1)
- [F1]Represents 5,000 shares of the Issuer's common stock, par value $0.0001 per share, acquired by the reporting person in an open market transaction.